Search results
Alembic Pharmaceuticals gets USFDA approval for Bromfenac Ophthalmic Solution - CNBC TV18
CNBC TV18· 18 hours agoThe newly approved ANDA is therapeutically equivalent to the reference listed drug product, Prolensa...
Alembic Pharmaceuticals receives final US FDA approval for Bromfenac Ophthalmic Solution, 0.07 per...
The Economic Times· 17 hours agoBromfenac Ophthalmic Solution 0.07 per cent is a nonsteroidal anti-inflammatory drug (NSAID)...
Alembic Pharma receives USFDA nod for Bromfenac Ophthalmic Solution
Business Standard India· 16 hours agoThe drug is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of...